CLOV vs EDIT
Clover Health Investments Corp (CLOV) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CLOV currently screens at market cap $1.55B. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CLOV and EDIT stock pages for the full models.
Not investment advice.